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The ferredoxin nicotinamide adenine dinucleotide phosphate reductase from Pseudomonas
aeruginosa (pa-FPR) in complex with NADP+ has been characterized by X-ray crystallography and
in solution by NMR spectroscopy. The structure of the complex revealed that pa-FPR harbors a preformed NADP+ binding pocket where the cofactor binds with minimal structural perturbation of the
enzyme. These findings were complemented by obtaining sequential backbone resonance
assignments of this 29,518 kDa enzyme, which enabled the study of the pa-FPR-NADP complex by
monitoring chemical shift perturbations induced by addition of NADP+ or the inhibitor, adenine
dinucleotide phosphate (ADP), to pa-FPR. The results are consistent with a pre-formed NADP+
binding site and also demonstrate that the pa-FPR-NADP complex is largely stabilized by
interactions between the protein and the 2′P AMP portion of the cofactor. Analysis of the crystal
†This work was supported by a grant from the National Institute of Health, GM-50503 (M.R.)
‡Coordinates for the structure of pa-FPR-NADP have been deposited in the protein data bank under accession code 3CRZ. Backbone
resonance assignments for pa-FPR have been deposited in the BMRB under access code 15788
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P. aeruginosa Pseudomonas aeruginosa
A. vinelandii

Azotobacter vinelandii

R. capsulatus

Rhodobacter capsulatus

P. pastoris

Pichia pastoris

FNR

ferredoxin NADP+ reductase

pa-FPR

Pseudomonas aeruginosa ferredoxin nicotinamide adenine dinucleotide phosphate reductase

Av-FPR

Azotobacter vinelandii ferredoxin reductase

FAD

flavin adenine dinucleotide

NAD(P)H

nicotinamide adenine dinucleotide (phosphate)

adenonsine 2′,5′-diphosphate
(ADP)
IPTG

isopropyl-1-thiol-D-galactopyranoside

DTT

dithiothreitol
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structure also shows a vast network of interactions between the two cofactors, FAD and NADP+,
and the characteristic AFVEK258 C’-terminal extension that is typical of bacterial FPRs but is absent
in their plastidic ferredoxin NADP+ reductase (FNR) counterparts. The conformations of NADP+
and FAD in pa-FPR place their respective nicotinamide and isoalloxazine rings 15 Å apart and
separated by residues in the C’-terminal extension. The network of interactions between NADP+,
FAD and residues in the C’-terminal extension indicate that the gross conformational rearrangement
that would be necessary to place the nicotinamide and isoalloxazine rings parallel and adjacent to
one another for direct hydride transfer between NADPH and FAD in pa-FPR is highly unlikely. This
conclusion is supported by observations made in the NMR spectra of pa-FPR and pa-FPR-NADP,
which strongly suggest that residues in the C’-terminal sequence do not undergo conformational
exchange in the presence or in the absence of NADP+. These findings are discussed in the context
of a possible stepwise electron-proton-electron transfer of hydride in the oxidation of NADPH by
FPR enzymes.
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Ferredoxin NADP+ reductases (FNRs), which catalyze the reversible electron transfer between
NADP(H) and their cognate ferredoxin or flavodoxin partners, are found in plastids,
phototropic and heterotropic bacteria and in mitochondria (1). One of the best characterized
enzymes is FNR from spinach leaves, a typical FNR found in plastids, which utilizes the
reducing power of electromagnetic radiation to reduce NADP+ and produce the NADPH
needed for subsequent photosynthetic paths (2). In contrast, bacterial ferredoxin reductases
oxidize the NADPH pool, in order to use this reducing potential in a large number of
oxidoreductive processes. For instance, E. coli flavodoxin reductase functions in the reduction
of flavodoxin for the activation of anaerobic enzymes and in the oxidation of NADPH as a
mechanism of protection against oxidative stress (3-5). In R. capsulatus (5), A. vinelandii (4)
and E coli (3) the gene fpr encodes a ferredoxin (flavodoxin) nicotinamide adenine dinucleotide
phosphate reductase (FPR) that functions in the oxidation of NADPH as a mechanism of
defense against oxidative stress. A similar FPR in P. aeruginosa (pa-FPR) has been
characterized as a 258-residue long NADPH-dependent enzyme that uses FAD as cofactor
(6). Although it is possible that pa-FPR also functions in mitigating oxidative stress (4), it has
been shown that under iron starvation conditions it functions by shuttling electrons from
NADPH to a heme oxygenase, thus supporting the process of releasing iron from exogenously
acquired heme for subsequent metabolic use (6).
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The crystal structure of pa-FPR (6) revealed a fold very similar that characteristic of the FNR
superfamily and is almost identical to the structure of FPR from A. vinelandii (Av-FPR) (7),
R. capsulatus (8) and E. coli flavodoxin reductase (9). Comparative analysis of the X-ray crystal
structures of ferredoxin reductases uncovered some interesting differences in the context of a
similar fold. These differences led to the classification of these enzymes into reductases of the
plastidic class, i.e., enzymes from chloroplasts and cyanobacteria, and enzymes of the bacterial
class, which are further subdivided into proteobacteria subclass I enzymes (A. vinelandii, R.
capsulatus, P. aeruginosa) and proteobacteria subclass II reductases (E. coli flavodoxin
reductase) (10). The structures showed that plastidic FNRs and bacterial FPRs differ in the
conformation and chemical environment of the FAD cofactor. In the plastidic enzymes the
FAD is bound in an extended conformation, which is stabilized by specific interactions with
residues in a sheet-loop-sheet motif (green in Figure 1-A). These encompass π-stacking of the
adenine ring with the conserved aromatic side chain of Tyr120 and hydrogen bonding
interactions involving the 2′-P AMP moiety. In comparison, bacterial FPRs lack the sheetloop-sheet motif that stabilizes the extended FAD conformation, thus the cofactor adopts a
folded conformation, where the adenine ring π-stacks with the conserved aromatic side chain
of residue 255 (Figure 1-B). The FMN portion of FAD in plastidic and bacterial reductases
exhibit very similar conformations and chemical environments. Additional important
differences occur in the carboxyl terminal domains, which are typically thought to be involved
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in NADP(H) binding. Whereas in plastidic FNRs the carboxyl terminal Tyr (Y314 in spinach
FNR, Y308 in pea FNR and Y303 in Anabaena FNR) π-stacks against the isoalloxazine ring
of FAD (11,12) (see Figure 1-A), in subclass I bacterial FPRs this residue is replaced by Ala254,
which is followed by a FVEK258 terminal sequence (Figure 1-B). In the structures of pa-FPR
and Av-FPR the carbonyl oxygen of Ala254 packs against the isoalloxazine ring, replacing the
conserved π-stacking interaction between the carboxyl terminal Tyr ring and the isoalloxazine
ring seen in plastidic FNRs. In subclass II bacterial enzymes, a conserved terminal Trp is found
immediately after the position occupied by the terminal Tyr in plastidic enzymes, thus
extending the carboxy terminal domain by only one residue. In these enzymes FAD also adopts
a folded conformation.
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The binding of NADP+ to FNRs has been the subject of intense investigations.
Cocrystallization of Anabaena FNR (13) with NADP+ revealed a complex in which the 2′P
AMP portion of the cofactor is stabilized in a manner similar that observed in the NADP+
complex obtained by soaking crystals of the Anabaena enzyme in NADP+ solution (14). The
conformation of the nicotinamide portion of the cofactor, however, is clearly distinct in the
two structures. In the structure of Anabaena FNR obtained from crystals soaked in NADP+
solutions the nicotinamide ring extends toward the surface of the protein and away from the
isoalloxazine ring, whereas in the structure obtained from co-crystallization with NADP+, the
side chain of the carboxyl terminal Tyr (Y303) is stacked between the nicotinamide and
isoalloxazine rings. The latter structure resembles more the “productive” interactions seen in
other flavoenzyme families that are structurally and functionally different from FNRs (i.e.
glutathione reductase) where the nicotinamide and iosalloxazine rings stack parallel and
adjacent to one another (15,16). Nevertheless, the side chain of Tyr303 is not displaced to allow
direct overlap of the cofactor rings, as would be expected in a “productive” complex that
facilitates direct hydride transfer. A “productive” complex was observed only in Y308 mutants
(the C’-terminal residue) of pea-FNR, where the NADP+ nicotinamide ring is nearly parallel
and adjacent to the FAD isoalloxazine ring (17).

NIH-PA Author Manuscript

These observations have led to the conclusion that NADP+ binding to FNRs is a two-step
process (17). In the first step the 2′-P-AMP moiety binds tightly and anchors the cofactor,
whereas the niconinamide portion is disordered. In the second step, the enzyme-cofactor
complex is expected to sample a set of “productive” conformations in which the side chain of
the C’-terminal Tyr is displaced, thus allowing overlap of the nicotinamide and isoalloxazine
rings to facilitate hydride transfer. In the context of this mechanism, it is significant that in the
structures of FPRs from A. vinelandii, R. capsulatus and P. aeruginosa the terminal Tyr is
replaced by Ala254, which is followed by a C’-terminal extension (AFVEK258). This extension
of the sequence, in principle, can be expected to slow the rate of conformational rearrangements
needed to access the “productive” conformation of cofactors thought to facilitate direct hydride
transfer, assuming that the binding of NADP+ is similar in FNRs and FPRs. Nevertheless,
nothing is known about the structural properties of the NADP(H) complex of FPRs, and the
functional role, if any, played by the C’-terminal extension characteristic of these enzymes has
so far been elusive. In this report we present the X-ray crystal structure of the pa-FPR-NADP
complex, which shows an extensive network of interactions between FAD, NADP+ and the
C’-terminal extension. Complementary observations made with the aid of NMR spectroscopy
in solution support the notion inferred from analysis of the network of interactions in the crystal
structure that the C’-terminal tail is not dynamically active, even upon NADP+ binding. These
findings, which suggest that the C’-terminal extension will likely not be readily displaced to
allow “productive” packing of the isoalloxazine and nicotinamide rings for direct hydride
transfer, are discussed in the context of a possible multistep hydride transfer operative in the
oxidation of NADPH by FPR enzymes.
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Expression of labeled pa-FPR for NMR Studies
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pa-FPR was expressed and purified following previously reported protocols (6). For the
expression of 15N labeled pa-FPR 1.0 L-cultures were incubated at 37 °C in medium containing
non-labeled nutrients. Upon reaching mid-log phase the cells were centrifuged and transferred
to the same volume of fresh minimum medium containing labeled 15NH4Cl (1.0 g/L) and
cultured to an optical density at 600 nm (OD600) of approximately 0.7. The culture was then
transferred to a shaker incubator pre-equilibrated at 10 °C where the cells were cultured for 30
min to allow thermal equilibrium. Protein expression was then induced by addition of IPTG
(0.3 mM final concentration), followed by culturing at 10 °C for approximately 14 h before
harvesting by centrifugation. Uniformly 13C and 15N-labeled pa-FPR, [U-13C, 15N]-pa-FPR,
was expressed in a similar manner, except that cells centrifuged after reaching mid-log phase
were resuspended in minimal medium containing 15NH4Cl (1.0 g/L) and 13C6-D-glucose (2.0
g/L). Prior to expression, the ArcticExpress™ RIL cells harboring the recombinant plasmid
containing the pa-fpr gene were adapted to grow in D2O using a protocol similar to that reported
for the expression of deuterated proteins in P. pastoris (18). In short, cells were plated on an
LB-ampicillin plate and grown at 37 °C for 16 h. An isolated colony from this plate was
transferred to 10 mL of LB-ampicillin medium containing 25% D2O (v/v) and the cells grown
at 37 °C overnight. The resultant cell suspension was used to plate LB-agar containing 25%
D2O and the cells were grown at 37 °C for 16 h. An isolated colony from this plate was
transferred to 10 mL of LB-Amp medium (50% D2O v/v) to start a new cycle of adaptation.
Subsequent cycles were carried out similarly and included adaptation at 75% and 95 % D2O.
Cells grown in 95% D2O were used to make a glycerol stab culture stock. A single colony of
cells grown in an LB-amp plate made with 95% D2O was transferred to 10 mL of LB-Amp
(99.9% D2O) and cultured at 37 °C and 220 rpm overnight. This culture was used to inoculate
100 mL (99.9% D2O) M9 medium containing 15NH4Cl (1.0 g/L) and 3C6-D-glucose (2.0 g/L)
and the cells were grown at 37 °C to an OD600 of ~ 0.7. Fifty mL from this culture were used
to inoculate 1.0 L of M9 medium (99.9% D2O) containing 15NH4Cl (1.0 g/L) and 13C6-Dglucose (2.0 g/L), and the cells grown to an OD600 of ~ 0.7 at 37 °C. The culture was then
equilibrated at 10 °C, followed by induction of protein expression by the addition of IPTG (0.2
mM final concentration) and culturing at 10 °C for 30 h. Cell harvesting, cell lysis and enzyme
purification were carried out as described previously (6). Amide and side chain deuterons were
exchanged for hydrogen as follows: Pure protein was dissolved in 50 mM sodium phosphate
buffer (pH 7.0) containing 8 M urea, 100 mM NaCl, and 0.1 mM FAD to a final concentration
of ~ 8 μM and incubated at 37 °C for 3 h. This solution was dialyzed extensively against 50
mM sodium phosphate (pH 7.0) containing 100 mM NaCl, 10% (v/v) glycerol, 0.1 mM EDTA,
and 5 mM DTT at 4°C. The resultant solution was concentrated by ultrafiltration (Centricon
−10, MW cutoff 10 kDa) to 1.0 mL and loaded onto a Sephadex G-50 column (100 × 1.6 cm)
to remove free FAD and eluted with 50 mM sodium phosphate buffer (pH 7.0).
Selective amino acid labeling of pa-FPR was carried out following a protocol reported
previously (19) with some modifications (20). The minimal medium used to obtain uniformly
labeled protein was supplemented with the following amino acids (g/L) : L-Ala (0.5), L-Arg
(0.4), L-Asp (0.4), L-Asn (0.4), L-Cys (0.05), L-Gln (0.4), L-Glu (0.65), Gly (0.55), L-His (0.1),
L-Ile (0.23), L-Leu (0.23), L-Lys hydrochloride (0.42), L-Met (0.25), L-Phe (0.13), L-Pro (0.1),
L-Ser (2.10), L-Thr (0.23), L-Tyr (0.17), L-Val (0.23), and L-Trp (0.05). All amino acids except
L-Trp and the 15N-enriched amino acid were added in solid form to the media prior to
autoclaving. 15N-Trp was filter sterilized and added prior to inoculation. For the preparation
of [15N-Leu]-pa-FPR, 10 mL of LB medium was inoculated with a single colony and grown
overnight at 37 °C. The overnight culture was used to inoculate 1.0 L of M9 medium
supplemented as above, but not containing L-Leu. The cells were grown at 37 °C to an
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OD600 of ~ 0.7, equilibrated at 10 °C and supplemented with 15N-L-Leu previous to induction
of protein expression by the addition of IPTG (of 0.2 mM final concentration)and cultured for
12~15 h. The same process was used to prepare pa-FPR labeled selectively with 15NVal, 15N-Glu, 15N-Phe and 15N-Asp. A slight modification was needed to prepare enzyme
labeled with 15N-Tyr, 15N-Phe and 15N-Thr. In the preparation of [15N-Tyr]-pa-FPR and
[15N-Phe]-pa-FPR, 0.25 g of glyphosate (N-phosphonomethyl-glycine) was added together
with the 15N-labeled amino acid. In the preparation of [15N-Thr]-pa-FPR, additional 0.23 g/L
of L-Ile and 0.115 g/L of L-Val were added together with the 15N-Thr to minimize isotope
scrambling to Ile or Val. In the preparation of [15N-Gly]-pa-FPR, the relatively minor
scrambling from 15N-Gly to 15N-Ser was intentionally preserved because it was useful in the
identification of cross-peaks originating from Ser residues in pa-FPR. Cell harvesting, cell
lysis and enzyme purification were carried out as described previously (6).
NMR Sample Preparation
Protein concentrations were determined by measuring the absorption of pa-FPR solutions at
450 nm (ε450 = 11.5 mM−1 cm−1) (6). NMR samples typically contained 0.1 – 1.2 mM paFPR, 5 – 10 % D2O in 50 mM sodium phosphate buffer (pH = 7.0). The details of experimental
conditions used for specific NMR experiments are shown in the appropriate figure captions.
NMR Spectroscopy and Backbone Resonance Assignments
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NMR experiments were carried out in a Bruker Avance 800 spectrometer equipped with a 5
mm TXI 1H-13C/15N/Dxyz gradient probe. Two- and three-dimensional NMR experiments
(1H-15N-HSQC, 1H-15N-TROSY-HSQC, HNCA, HN(CO)CA, TROSY-HNCACB, TROSYHN(CO)CACB, TROSY-HN(CA)CO, and TROSY-HNCO) for NMR assignment were
carried out at 25 °C. Amino acid selective 15N-labeled pa-FPR: [15N-Gly]-pa-FPR, [15N-Leu]pa-FPR, [15N-Val]-pa-FPR, [15N-Glu]-pa-FPR, [15N-Phe]-pa-FPR, [15N-Asp]-pa-FPR,
[15N-Tyr]-pa-FPR and [15N-Thr]-pa-FPR were used to acquire 1H-15N HSQC spectra. Twoand three-dimensional NMR spectra were processed using NMRPipe and analyzed with
Sparky. 1H chemical shifts were referenced to the proton resonance of DSS at 0 ppm,
while 15N and 13C shifts were referenced indirectly using the ratios 0.101329118 and
0.251449530, respectively (21).
Chemical Shift Perturbation Experiments
1H-15N HSQC spectra were recorded at 25 °C using Varian Unity Inova 600 MHz and Bruker
Avance 800 MHz spectrometers. [15N]-pa-FPR (500 μL, 0.25 mM) in 50 mM sodium
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phosphate (pH 7.0, 10 % D2O) contained in a 5 mm diameter NMR tube was titrated with a
stock solution of NADP+ (39 mM) dissolved in the same buffer. Titrations were carried out
by addition of 0.05, 0.10, 0.20, 0.30, 0.40, 0.50, 0.75, 1.0, 1.5, 2.0, 3.5, 5.0, 7.5, 10, 15, 20 and
25 equivalents of NADP+ relative to pa-FPR. The pH of the solution after the addition of each
aliquot of NADP+ was adjusted to 7.0 prior to recording the corresponding 1H-15N HSQC
spectrum. The spectra were acquired at 25 °C using Varian Unity Inova 600 MHz. The data
were processed using NMRpipe and analyzed using Sparky. Similar experiments were carried
out with adenosine 2′5′-diphosphate (ADP), a competitive inhibitor of ferredoxin reductase
enzymes.
X-ray crystallography
X-ray-quality single crystals of pa-FPR in complex with NADP+ were grown using the hanging
drop vapor diffusion method by mixing 2 μL of pa-FPR (20 mg/mL) dissolved in 20 mM Tris
(pH 7.6) containing 10 mM NADP+ with 2 μL of a solution consisting of 200 mM ammonium
acetate, 100 mM sodium citrate tribasic dihydrate and 25% PEG-4000 (pH 5.6). Diffraction
data were recorded at −180 °C using the rotation method on a single flash-frozen crystal
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[Detector: R-axis IV++ image plate; X-rays: CuKα, focused by mirror optics; Generator:
Rigaku RU300 (MSC, The Woodlands, TX, USA)]. The cryoprotectant was 20 % ethylene
glycol. X-ray data were reduced with XDS (22); the program package CNS (23) was employed
for phasing and refinement; model building was performed with O (24). The structure was
solved by molecular replacement using the coordinates of ferredoxin oxidoreductase from
pa-FPR (PDB entry 2QDX) as search model, stripped of solvent molecules and ligands.
Refinement was performed using data to the highest resolution with no sigma cut-off applied.
Several rounds of minimization simulated annealing (2500 K starting temperature) and
restrained individual B-factor refinement were carried out. Data collection and refinement
statistics are summarized in Table 1.

RESULTS AND DISCUSSION

NIH-PA Author Manuscript

Precedents guiding current views of hydride transfer between flavin and nicotinamide are
grounded on observations made with the structure of glutathione reductase, a flavoenzyme that
is functionally and structurally different from FNR (15,16). The structure of glutathione
reductase shows the nicotinamide ring parallel and adjacent to the isoalloxazine ring; this
relative orientation, which likely facilitates direct hydride ion transfer, is viewed as a
“productive” complex. In the structures of plastidic FNRs, however, the side chain of the C’terminal Tyr lies parallel to the flavin isoalloxazine ring, thus occupying the place that would
be taken by the nicotinamide ring in a “productive” complex. Work aimed at explaining these
structural observations led to the hypothesis that NADP+ binding to plastidic FNRs is a two
step process; with the first step involving strong interactions between the 2′ adenosyl phosphate
moiety and FNR, whereas the nicotinamide portion undergoes less specific interactions with
the enzyme. In the second step the side chain of the terminal Tyr moves and allows the
nicotinamide ring to stack parallel to the isoalloxazine ring, thus forming a transient but
“productive” complex conducive to direct hydride transfer (17).
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In comparison, previous to this report, virtually nothing was known regarding the binding of
NADP+ to bacterial FPRs. Amino acid sequence alignments and the structures of Av- and paFPRs had demonstrated that the position occupied by the terminal Tyr in FNRs is occupied by
Ala in the bacterial enzymes (A254 in pa-FPR), where the carbonyl oxygen of this residue
stacks against the isoalloxazine ring of FAD (6,7). In addition, FPR enzymes possess a
characteristic C’-terminal extension following A254 (AFVEK258). The effect of NADP+
binding on the interaction between A254 and FAD and on the conformation of the C’-terminal
extension, however, was difficult to predict. The structure of the pa-FPR-NADP complex
reported herein provides a first view of the interactions between NADP+ and pa-FPR. As will
be shown below, analysis of the structure shows a vast network of stabilizing interactions
between FAD, NADP+ and the C’-terminal extension, which suggests that the gross
conformational rearrangements that would be needed for placing the nicotinamide and
isoalloxazine rings parallel and adjacent is not likely to occur. These observations are discussed
in the context of a putative mechanism where the oxidation of NADPH by FPRs may occur
via a stepwise rather than direct hydride transfer.
The Crystal Structure of pa-FPR-NADP shows a network of interactions encompassing FAD,
NADP+ and the C’-Terminal Extension
The recently reported crystal structure of pa-FPR (6) showed that the enzyme folds into a twodomain structure, typical of the ferredoxin NADP+ reductase superfamily. The FAD cofactor
binds in the N-terminal domain (residues 1–87), comprised of an antiparallel β-barrel (β1-β6)
capped by helix α1. The stabilizing interactions between FAD and pa-FPR have been described
in detail (6); these interactions remain largely unchanged in the structure of the pa-FPR-NADP
complex, which shows that NADP+ binds in the C’-terminal domain of the β-sheet, comprised
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of β7, β10, the loop connecting β7 to α3, the N-terminal residues of α3 and the carboxy terminal
residues AFVEK258 (Figure 2). There are several stabilizing interactions between the
polypeptide and the cofactor (Figure 3): Starting at the adenine end of the NADP+ molecule,
the NH2 nitrogen in this ring is within hydrogen bonding distance of the hydroxyl oxygen in
Ser223 and the carboxylate group of Glu227. The 2′-phosphate (2′-P) is anchored to the enzyme
via H-bonds and salt bridges to the hydroxyl oxygen of Thr181, the guanidinium NH and
NH2+ groups in the side chain of Arg182 and the guanidinium NH group of Arg190. A salt
bridge between the negatively charged oxygen in the pyrophosphate P1 group of NADP+ and
the guanidinium NH2+ group of Arg145, and a hydrogen bond between the NH group of the
same side chain and the neutral oxygen in P1 stabilize this portion of the cofactor. The 1′- and
2′-hydroxyl groups in the nicotinamide ribose ring of NADP+ are engaged in hydrogen bonding
interactions with the adenine 3N atom and with the ribose 2-hydroxyl groups of FAD,
respectively. It is important to point out that despite the proximity suggested by these
interactions, the isoalloxazine and nicotinamide rings of FAD and NADP+ are separated by
the C’-terminal residues. This network is expanded by π-stacking interactions between the
adenine ring in FAD and the aromatic side chain of Phe255; the latter is also T-stacked against
the nicotinamide ring of NADP+. The nicotinamide amide NH and cabonyl groups are within
hydrogen bonding distance of the carboxylate group in Glu257 and the backbone N-H of Ser
223, respectively. The carboxylate group of Glu257 expands the network by hydrogen bonding
with the 1-hydroxyl group in the AMP portion of FAD. Lys258 complements the network with
electrostatic and hydrogen bonding interactions with FAD that involve the side chain NH3+
with the 2 pyrophosphate group and the terminal carboxylate with the 2′-ribityl hydroxyl,
respectively.
Three important observations emerge from this analysis: (1) Residues in the AFVEK258
extension form an integral part of a complex network of interactions that associate the FAD
and NADP+ cofactors with the enzyme. (2) The C’-terminal extension would have to undergo
extensive conformational rearrangements to permit the formation of a “productive” complex
with the nicotinamide and isoalloxazine rings stacked parallel and adjacent to one another. (3)
Parallel stacking of these rings would also require large conformational changes in FAD, which
would have to change from its folded conformation to perhaps the extended conformation
characteristic of plastidic FNRs. This is unlikely because the folded conformation of FAD is
stabilized by the network of interactions with NADP+ and the C’-terminal extension and
because the absence of a sheet-loop-sheet motif in FPRs (see Figure 1) renders the enzyme
incapable of stabilizing FAD in its extended conformation.
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Consequently, in the context of current models for NADP+ binding to plastidic FNR enzymes,
it seems unlikely that binding of the cofactor to pa-FPR would trigger the gross conformational
rearrangement needed to allow parallel and adjacent placement of the nicotinamide and
isoalloxazine rings in the pa-FPR-NADP complex. This in turn suggests that formation of a
“productive” complex, in the sense of NADP+ binding to plastidic FNR, is not likely to occur
with a frequency (μs-ms) conducive to catalytical competence.
The Structure of pa-FPR Harbors a Pre-Formed NADP+ Binding Pocket
The binding of NADP+ brings about relatively minor structural changes to pa-FPR, as can be
seen in the per-residue plot of ΔCα (Figure 4-A), obtained by aligning the structures of pa-FPR
and pa-FPR-NADP. The largest differences in Cα position, taken as ΔCα > 1.5 times the average
rmsd (0.47 Å) obtained from the alignment, are localized in the N-terminal of helix α10
(residues 221–225), the middle of the loop connecting α10 to β11 (residues 242–244) and the
carboxy terminal Lys 258. Among the affected amino acids, residues 221–225 and 258 are
located in close proximity to the bound NADP+, whereas residues 242–244 are distant; the
differences in Cα position seen for the latter are likely a consequence of the higher than average
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B-factors exhibited by these residues. Figures 4-B and 4-C illustrate a portion of the surface
of pa-FPR and pa-FPR-NADP, respectively. The side-by-side comparison reveals that the
surface of pa-FPR has a pre-formed cavity where the NADP+ cofactor binds to form the paFPR-NADP complex with minimal perturbation of the pa-FPR structure.
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It is well known that NADP+-dependent enzymes cannot substitute this cofactor for NAD+, a
fact that is also evident in the negligible catalytic activity observed with pa-FPR when NADPH
is replaced with NADH (6). Site directed mutagenesis studies indicated that stabilization of
the 2′-P in NADP+ contributes significantly to the mechanism whereby NADP(H) dependent
FNR enzymes discriminate against NAD(H) (25,26). In this context, it is interesting that in the
crystal structure of pa-FPR a sulfate anion (from the crystallization solution) is nearly
isostructural with the 2′-P group of NADP+ in the crystal structure of the pa-FPR-NADP
complex. This is illustrated in Figure 4, where the sulfate in the structure of pa-FPR (Figure
4-D) exhibits interactions nearly identical those shown by the 2-′P group in the structure of the
pa-FPR-NADP complex (Figure 4-E). These observations are in good agreement with the idea
that the structure of pa-FPR harbors a pre-formed binding pocket, where residues involved in
important contacts with the 2′P group of NADP+ require little or no rearrangement to
accommodate the cofactor. Among these residues, R182 and R190 are conserved in bacterial
subclass II reductases, Thr181 is conserved in bacterial subclass I enzymes and substituted for
Ser in plant reductases (Ser223 in spinach FNR) and R182 is conserved in all enzymes with
known sequence.
Assignment of Amide Backbone Resonances from pa-FPR

NIH-PA Author Manuscript

NMR spectroscopy studies were carried out to obtain complementary information in solution
regarding the binding of NADP+ to pa-FPR. Before these investigations could begin, however,
it was necessary to obtain sequential backbone resonance assignments. The relatively large
molecular weight of the enzyme (29,518 Da) posed some challenges. These were overcome
with the strategy described below. The 1H-15N HSQC spectrum of pa-FPR acquired at 25 °C
from a 1.2 mM solution of pa-FPR in 50 mM sodium phosphate buffer, pH 7.0 is shown in
Figure 5-A. These conditions were chosen for the NMR spectroscopic studies because they
completely eliminate the slow precipitation of the enzyme when its concentration exceeds 1.5
mM or when the samples are exposed to temperatures above 25 °C for 24 h or longer. The
spectrum exhibits relatively well dispersed cross-peaks, despite the relatively large molecular
weight of the enzyme. Conventional heteronuclear 2D and 3D NMR experiments (see
Experimental) carried out with a sample of pa-FPR uniformly labeled with 13C and 15N did
not yield enough information to permit full sequential assignments. This is mostly because
many residues exhibited weak or absent beta carbon (Cβ) correlations in TROSY-HNCACB
and TROSY-CBCA(CO)NH experiments, which is attributed to efficient transverse relaxation
brought about by the dipolar interactions between carbons and their attached protons (27). This
problem was circumvented by preparing a sample of [U-2H, 13C, 15N]-pa-FPR, which was
used to acquire TROSY-HNCACB and TROSY-CBCA(CO)NH experiments for subsequent
use with the data obtained from the suite of experiments obtained with [U-13C, 15N]-pa-FPR.
This approach allowed us to assign approximately 85% of the non-proline residues in the
enzyme. With respect to [U-2H, 13C, 15N]-pa-FPR, it should be noted that although most of
the exchangeable deuterons exchanged for protons during its purification, several residues are
clearly protected from exchange because a number of cross-peaks displayed low-intensity or
were absent when the HSQC spectrum of [U-2H, 13C, 15N]-pa-FPR was compared with that
obtained from a sample of [U-15N, 13C]-pa-FPR. Deuterons protected from exchange under
native conditions were exchanged by dissolving the triply labeled sample in a urea containing
solution, followed by dialysis in the presence of FAD. This unfolding/refolding procedure
resulted in complete replacement of exchangeable deuterons for protons, as indicated by the
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fact that the TROSY-HSQC spectrum of the resultant enzyme is identical that obtained with
doubly labeled pa-FPR.
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Additional assignments were obtained by incorporating amino acid-selective 15N labeling into
pa-FPR. This strategy has been successfully utilized in our laboratories to complete the
sequential backbone resonance assignments of a paramagnetic, highly helical heme oxygenase
from P. aeruginosa (28). In the context of assigning the backbone resonances from pa-FPR,
selective labeling was important in our strategy for two main reasons. (1) Nearly undetectable
isotopic scrambling was observed with 15N-Leu, 15N-Phe, 15N-Val and 15N-Thr, as can be
seen in the corresponding HSQC spectra (Figures S1-A to S1-D). Labeling with 15N Gly
scrambles the label to Ser (Figure S1-E). This type of scrambling, however was found to be
useful because it aided in the identification of cross-peaks originating from Ser residues. The
label in 15N-Tyr also scrambles, albeit less selectively than the label in 15N-Gly. Nevertheless,
the information in the HSQC spectrum of 15N-Tyr labeled pa-FPR (Figure S1-F) is valuable
because most of the cross-peaks originating from 15N-Tyr are significantly stronger than cross
peaks originating from scrambled label. In contrast, the label in 15N-Glu and 15N-Asp is highly
scrambled, as can be seen in the corresponding HSQC spectra of Figures S1-G and S1-H,
respectively; these spectra were not very useful to the assignment process. Information
obtained from selectively labeled samples was subsequently used in conjunction with the
backbone connectivities derived from the suite of three-dimensional experiments described
above in order to make the sequential assignments. This approach was essential to assign
stretches in a sequence where spin systems of key residues within a segment could not be
identified due to poor detection of Cβ resonances. (2) The simplicity of HSQC spectra obtained
from most amino acid-selective 15N-pa-FPR samples allow identification of cross-peaks that
can be easily overlooked in the spectrum of [U-15N]-labeled samples, because of overlap with
other resonances or due to relative low intensity. For instance, in the HSQC spectrum of 15NGly-pa-FPR the cross-peak in red corresponds to G205 (Figure S2). The same cross-peak is
located in a crowded section of the spectrum obtained with [U-15N]-labeled enzyme and thus
it had been overlooked. Its definitive identification in the spectrum of the 15N-Gly-pa-FPR
allowed its subsequent sequential assignment with the aid of the suite of three-dimensional
experiments described above. In the end, the combined strategies allowed us to make 95% of
backbone assignments in pa-FPR, not counting Pro; these assignments are summarized in
Table S1.
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Once assigned, the backbone chemical shifts were used to identify elements of secondary
structure in solution by chemical shift indexing (CSI) (29). Results obtained from this process
carried out with Cα chemical shifts have been plotted per residue in Figure 5-B, where they are
compared with elements of secondary structure obtained from the crystal structure of pa-FPR
using the program DSSP (http://swift.cmbi.ru.nl/gv/dssp/). It is apparent that secondary
structure identified with the aid of NMR spectroscopic studies in solution is consistent with
secondary structure obtained from the enzyme in crystal form. The most significant differences
are in residues 191–197 (α8) and residues 199–204 (α9). The backbone resonances of residues
in α8 were not assigned, most likely because the NH cross-peaks of these residues are very
weak or unobservable in HSQC spectra, due to line broadening brought about by segmental
dynamic behavior. Cross-peaks from residues 199–204, although observable, are significantly
less intense than average, suggesting that these residues are also affected by dynamic
conformational exchange. Hence, it is likely that this segment of the structure in solution is
conformationally averaged between helical and disordered states; the fact that α8 and α9 are
flanked by loops likely facilitates this segmental dynamic behavior. Interestingly, the crystal
structure of the pa-FPR-NADP complex shows that α8 and α9 are in close proximity to the
NADP+ binding site, which suggests the possibility that local conformational plasticity
prepares the enzyme to bind the NADP(H) cofactor.
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Probing the Binding of NADP+ to pa-FPR in Solution by NMR Chemical Shift Perturbations
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The binding of NADP+ to pa-FPR was studied by titrating NADP+ into a solution
containing 15N-labeled pa-FPR, while monitoring induced chemical shift perturbations of
amide 1H and 15N resonances with the aid of 1H-15N-HSQC spectra. The titration induced
chemical shift perturbations larger than two times the average of the weighted chemical shift
perturbation (0.12 ppm) in 22 cross-peaks, a characteristic that identifies the corresponding
residues as potential sites of interaction with NADP+. The NADP+-dependent gradual shift of
cross-peaks indicate that interconversion between NADP+-bound and free forms of the enzyme
is fast relative to the NMR timescale (i.e. fast exchange). The titration also caused the
disappearance of 18 cross-peaks, which is likely a consequence of exchange between bound
and free forms at rates approximately equal to the chemical shift timescale (i.e. intermediate
exchange). Cross-peaks exhibiting gradual chemical shift perturbations have been plotted perresidue (black in Figure 6-A), together with cross-peaks that disappear upon addition of
NADP+ (red in Figure 6-A). The plot makes it evident that those residues whose chemical
shifts exhibit gradual chemical shift perturbations (fast exchange) are clustered with residues
whose chemical shifts disappear during the titration, which strongly suggests that line
broadening of the latter is a consequence of binding interactions that trigger dynamic events
taking place in the intermediate exchange regime. The NADP+-dependent chemical shift
perturbation of cross-peaks in fast exchange has been plotted for several representative amino
acids (V144, W146 and V147) in Figure S3-A and the curve fitted to a model where one
molecule of pa-FPR binds one molecule of NADP+. This analysis reveals an average
dissociation constant (Kd) of 24 μM, a value similar that reported for the binding of NADP+
to spinach FNR (14 μM) at lower ionic strength (30).
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Residues whose N-H cross-peaks exhibit weighted chemical shift perturbations larger than
0.08 ppm upon titrating pa-FPR with NADP+ are highlighted in green on the X-ray crystal
structure of the pa-FPR-NADP complex (Figure 6-C), whereas residues whose N-H crosspeaks disappear are highlighted in red. It is reassuring that the chemical shifts of amide crosspeaks corresponding to residues identified in the crystal structure as being in close proximity
to NADP+ are perturbed by the presence of NADP+. Amongst these, cross-peaks from residues
interacting with the 2′-P group of NADP+, Thr181, Arg182 and Arg190 (see Figure 3), are
broadened and disappear due to exchange in the intermediate regime, whereas the cross-peak
originating from Glu257, which interacts with the amide NH2 group of the nicotinamide ring
exhibits perturbations in the fast exchange regime. Cross peaks for Arg145 and Ser223, which
interact with the pyrophosphate group P1, and with both the nicotinamide amide and the 2′P
groups of NADP+, respectively, have not been assigned. A comparison of the X-ray crystal
structures of pa-FPR and pa-FPR-NADP has been made in Figures 4-B and 4-C, which shows
that the structure of pa-FPR has a pre-formed “NADP+ binding pocket” where the cofactor
binds with minimal perturbations on the structure of the enzyme. In Figure 6-C, the cofactors
have been rendered in sticks to illustrate the fact that residues comprising the “internal walls”
of the “NADP+ binding pocket” are highlighted in red and green. This observation indicates
that the surface of interaction in the structure of NADP+ includes the “internal walls” of the
“NADP+ binding pocket”, and demonstrates that the chemical shift perturbations and line
broadening effects brought about by the binding of NADP+ in solution delineate a binding
surface highly consistent with that observed in the crystal structure. Hence, observations made
with the enzyme in solution also indicate that the structure of pa-FPR harbors a pre-formed
“NADP+ binding pocket”.
Current models of NADP(H) binding to plastidic FNRs propose that parallel stacking of the
nicotinamide ring onto the isoalloxazine ring to form a “productive” complex for direct hydride
transfer requires displacement of the side chain from the terminal Tyr. Equilibrium binding
studies conducted with spinach FNR revealed that its binding affinity for NADP+ is
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approximately seven times lower than its affinity for adenonsine 2′,5′-diphosphate (ADP)
(30), which lacks the nicotinamide nucleotide moiety. These observations have been
interpreted in the context of the binding model to support the idea that NADP(H) binding to
plastidic FNRs is a two-step process, with the first step involving strong interactions between
the 2′adenosyl phosphate and FNR, and the second step requiring displacement of the terminal
Tyr to allow the nicotinamide ring to stack parallel to the isoalloxazine ring of FAD. In this
model, the second step, which is thought to be energetically costly, has been invoked to explain
the higher affinity of FNR for ADP relative to NADP+ (17,31). It was therefore of interest to
examine the binding of ADP to pa-FPR and compare the results with those described above
for the binding of NADP+. Hence, ADP was titrated into a solution containing 15N-labeled
pa-FPR, while monitoring induced chemical shift perturbations in 1H-15N-HSQC spectra.
Remarkably, titration with ADP revealed a pattern of perturbed residues (Figure 6-B) nearly
identical to the pattern obtained upon binding of NADP+ to pa-FPR (Figure 6-A). This fact is
also evident in the corresponding color coded representation obtained by mapping residues
whose cross-peaks exhibit chemical shift perturbations (green) and line broadening effects
(red) on the structure of pa-FPR-NADP (Figure 6-D). Chemical shift perturbations induced by
addition of ADP to pa-FPR for several representative amino acids (V144, W146 and V147)
have been plotted and fitted to a model with stoichiometry 1:1 Figure S3-B. This process reveals
an average Kd of 32 μM, a value that is slightly larger than that measured for the pa-FPRNADP complex (see above). The similarity in the magnitudes of Kd obtained for the binding
of NADP+ and the competitive inhibitor ADP indicates that stabilization of the pa-FPR-NADP
complex is derived mainly from interactions between the polypeptide and the adenosine 2′, 5′diphosphate moiety in NADP+. In contrast to observations made with spinach FNR, however,
the binding affinity of pa-FPR for NADP+ is slightly larger than its affinity for ADP, which
indicates that the nicotinamide nucleotide moiety does not undergo destabilizing interactions
with the enzyme, as is thought to be the case in the binding of NADP+ to plastidic FNRs. It is
therefore likely that NADP+ binding to pa-FPR occurs in one step, rather than two, as is thought
to be the case when it binds to FNRs.
The C’-terminal sequence is unlikely to experience large conformational disorder
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As pointed out above, the X-ray crystal structure of pa-FPR revealed a network of interactions
involving the C’-terminal extension and the two cofactors, strongly suggesting that the C’terminal sequence of pa-FPR is not likely to be displaced readily in order to allow parallel
stacking of the nicotinamide and isoalloxazine rings. To examine whether the C’-terminal tail
is undergoing conformational fluctuations in solution we looked for signs of dynamic motions
manifested in the characteristics of HSQC cross-peaks. Peaks significantly affected by slow
conformational exchange (μs-ms) typically show decreased intensity and/or larger line-widths
than those originating from regions of a protein unaffected by such motions, provided the interconverting species in equilibrium are sufficiently populated (32,33). In this analysis, we
expected that residues located near the nicotinamide and isoalloxazine rings would be most
significantly affected by conformational exchange, and consequently display enhanced line
widths and/or decreased intensity relative to the average for all other peaks in the spectrum.
This notion was probed in solution by acquiring 1H-15N-HSQC spectra of pa-FPR, pa-FPRNADP and pa-FPR-ADP at different temperatures (35 °C, 25 °C and 15 °C) and at 600
MHz 1H frequency. Cross-peaks corresponding to the AFVEK258 sequence exhibit 1H
linewidths and cross-peak intensities that are very similar to the average 1H linewidths and
average cross-peak intensity at each of the temperatures in all spectra, implying that alternative
conformations are not significantly populated in the range of temperature explored, thus
suggesting that the C’-terminal extension is unlikely to undergo significant conformational
changes, in the presence or in the absence of NADP+. It is important to note that the data at
hand cannot completely rule out the presence of a dynamic equilibrium between a very low
population of molecules, where the cofactors attain a “productive conformation”, and a bulk
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population where the conformation of FAD and NADP+ is very similar to that in the crystal
structure, which dominates the HSQC spectrum. If this small population is indeed present, it
may be possible to study it with the aid of detailed dynamic studies, including analysis or R2
relaxation dispersion data (32,34). It is important to consider, however, that the population
with a “productive conformation” is low in the plastidic FNRs (~ 10%) (17), where only the
side chain of the terminal Tyr has to move to allow the nicotinamide ring of NADP+ to enter
the FAD-isoalloxazine environment. In comparison, the structure of the pa-FPR-NADP
complex indicates that for the nicotinamide ring to enter the isoalloxazine environment, a much
larger conformational rearrangement is necessary, which involves the AFVEK258 terminal
extension. Moreover, it is also important to consider that the conformation of FAD in pa-FPR
is bent and therefore distinct from the extended FAD conformation in plastidic FNRs (see
Figure 1). The bent conformation of FAD in bacterial FPR enzymes places the adenine ring
between the isoalloxazine and nicotinamide rings (see Figure 3). Consequently, for the
nicotinamide ring to enter the isoalloxazine ring environment in bacterial FPRs, the FAD has
to undergo a large conformational change, which very likely would expose a large portion of
the cofactor to the aqueous environment, thus making it prone to be released from the enzyme.
It is also conceivable that binding of NADPH instead of NADP+ promotes the large
conformational changes that would be needed to form a “productive” complex in FPRs. This
scenario, however, is also unlikely because the conformational changes necessary would still
involve the large amplitude motions of the C’-terminal sequence and of the FAD cofactor
discussed above. Hence, together, these considerations strongly suggest that the large
conformational changes that would have to take place on FPR to allow parallel and adjacent
placement of the nicotinamide and isoalloxazine rings for direct hydride transfer are unlikely.
Nevertheless, additional experimentation is necessary to continue to probe these ideas.
Potential Implications to the Mechanism of NADPH Oxidation by FPRs
The above-described observations suggest that conformational reorganization of the C’terminal peptide and of the NADP+ and FAD cofactors to allow formation of a “productive”
complex for direct hydride transfer is unlikely to take place in the pa-FPR-NADP complex. In
this context, it is important to consider that extensive fundamental investigations of the
mechanism of NAD(P)H oxidation have demonstrated that hydride transfer can also occur in
a stepwise manner by sequential electron-proton-electron transfer (35-44) (Equation 1). These
investigations documented the formation of radical cations and radicals of
Equation 1
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NAD(P)H and its analogues, which have been characterized with the aid of electronic
absorption and EPR spectroscopic methods. The formation and detection of these reactive
species indicated that the oxidation of NAD(P)H and its analogues can occur stepwise via
electron-proton-electron transfer of hydride, if the acceptor is also capable of undergoing a
stepwise two electron reduction. This point has been recently underscored with the EPR and
electronic absorption spectroscopic detection of a radical cation of an NADH analogue in the
thermal two-electron reduction of a quinone (35). Moreover, it has also been demonstrated that
in the absence of H2O2, the oxidation of NADH by native horseradish peroxidase (HRP) begins
with single-electron transfer from NADH to ferric HRP to form the NADH•+ radical cation
and ferrous peroxidase (39). A similar stepwise oxidation of NADPH is thought to be operative
in the rescue of inactive catalase (45). Hence, under appropriate circumstances the oxidation
of NAD(P)H by sequential electron-proton-electron transfer of hydride is a viable alternative
mechanistic path to the well-known direct mechanism involving synchronous transfer of a
proton and two electrons.
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It has also been established that long-range (up to 30 Å) electron transfer through proteins
occurs via tunneling pathways, which involve dominant bonding and nonbonding interactions
coupling donor and acceptor. Coupling through covalent and hydrogen bonds is stronger than
coupling through van der Waals gaps (46-48), and these differences in the details of specific
paths involved in distinct systems account for the dependence of electron transfer rates on the
particular aspects of the protein structure that mediate coupling of donor and acceptor (48). In
this frame it is interesting that the structure of the pa-FPR-NADP complex places C4 of the
nicotinamide ring 14.5 Å away from N5 of the isoalloxazine ring. Further inspection of the
structure suggests a “tunneling pathway” connecting the nicotinamide ring in NADP(H) with
the isoalloxazine ring in FAD. This putative path (Figure 7-A) can be thought to start with the
T-stacking of the nicotinamide and Phe255 rings, continue along Phe255 into Ala254 across
the peptide bond and finally communicate with the isoalloxazine ring via the Ala254 carbonyl
oxygen, which is 2.93 Å from the N10 and 3.93 Å from the N5 atom in the isoalloxazine ring.
In this putative mechanism, electron tunneling from the nicotinamide to the isoalloxazine ring
would form an NADPH•+ radical cation analogous that shown in Equation 1. Radical cations
of NADH model compounds are known to be significantly more acidic than their neutral
precursors (42), thus, the NADPH•+ radical cation formed upon tunneling of one electron would
be expected to lose a proton thereby forming an NADP• radical, as shown in Equation 1.
Tunneling of a second electron from the latter would form the closed shell NADP+.
Accordingly, the electron acceptor, FAD, can be reduced in two sequential one-electron and
one proton transfer reactions (49,50). In the context of a stepwise, electron-proton-electron,
hydride transfer, it is also interesting to note a network of structural water molecules in the
structure of the pa-FPR-NADP complex, which may facilitate proton translocation from
NADPH to FAD (Figure 7-B). In the same frame, it is also interesting to consider that amino
acid alignment of bacterial subclass I FPR enzymes (Figure 7-C) shows that the AFVEK258
extension of pa-FPR is present in all bacterial subclass I FPR enzymes of known sequence
(AFVxx). Furthermore, it is noteworthy that residues A254 and F255 in this motif, which we
implicate in the putative path of electron transfer (Figure 7-A), are conserved.
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It is important to emphasize that one-electron reduction of NAD(P)+ analogues does not result
in an overall hydride ion addition in the same manner in which one-electron oxidation of NAD
(P)H triggers a multistep hydride ion release (38). Hence, the proposed mechanism of NADPH
oxidation by FPRs is consistent with the fact that these enzymes function by exclusively
oxidizing the cofactor, unlike their plastidic counterparts, which function in the “normal” sense
by reducing NADP+ via hydride transfer from FADH2 or in the “inverse” sense by oxidizing
NADPH. It is therefore possible that the need to reduce NADP+ has placed evolutive pressure
on the structure of plastidic FNRs to allow parallel placement of the nicotinamide and
isoalloxazine rings for efficient hydride transfer and reduction of NADP+ in order to support
the high electron flow needed in the photosynthetic process of CO2 fixation (5). In comparison,
the function of FPR enzymes, which is solely the oxidation of NADPH, was acquired with
minor modifications of the C’-terminal domain, which make the direct transfer of hydride
(NADP+ reduction) unlikely but a multistep hydride transfer (NADPH oxidation) operative.
These ideas, which stem from the X-ray crystallographic and NMR spectroscopic observations
of the pa-FPR-NADP complex, have to be tested experimentally. Their discussion in this report
is aimed at providing a frame of ideas consistent with experimental observations and to
stimulate future experimentation directed at elucidating the mechanism of NADPH oxidation
by FPR enzymes.

Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.

(A) The fold of plastidic FNRs exhibits a conserved sheet-loop sheet motif (green) that
contributes to stabilizing the extended FAD (yellow) conformation characteristic of these
enzymes. (B) The fold of bacterial FPRs is devoid of the sheet-loop-sheet motif and exhibits
a characteristically bent FAD conformation and a C’-terminal extension (red).
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Figure 2.
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View of the structure of the pa-FRP bound to NADP+. FAD is shown in blue, NADP+ in cyan,
α-helices in red, β-sheets in yellow and loops in green.
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Figure 3.

Stereoview of a portion of the structure of pa-FPR-NADP highlighting the network of
stabilizing interactions between the C’-terminal extension (AFVEK258) and the cofactors. FAD
is shown in yellow and NADP+ in cyan, with their N, O and P atoms in blue, red and orange,
respectively.
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Figure 4.

(A) Per residue plot of the difference in the position of alpha carbons (ΔCα) obtained upon
aligning the structures of pa-FPR and that of its NADP+ complex. The average RMSD is 0.47
Å. (B) Close-up view of the empty “NADP-binding pocket” on the surface of pa-FPR; the
FAD is rendered in yellow sticks. (C) Equivalent view, obtained from the structure of the paFPR-NADP complex, highlighting NADP+ (blue sticks) lodged in its binding pocket. (D) The
structure of pa-FPR displays a sulfate ion (red) from the crystallization buffer that occupies
the position of the 2′-phosphate group in the pa-FPR-NADP complex (E). Note that the
interactions exhibited by the phosphate and sulfate ions are nearly identical.
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Figure 5.

(A) 1H-15N HSQC of 1.5 mM [U-13C,15N]-pa-FPR in 50 mM sodium phosphate, pH 7.0, and
6% D2O, obtained at 25 °C using a Bruker Avance800 NMR spectrometer. Complex points,
256 (1H) x 2048 (15N); spectral width, 14.4 kHz (1H) and 3.3 kHz (15N); 4 scans per increment,
recycle delay 0.8s. (B) Secondary structure in pa-FPR inferred from chemical shift indexing
(Cα), which can be compared to secondary structure inferred from the X-ray crystal structure
(top).
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Figure 6.
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(A) Per-residue plot of weighted chemical shift perturbations (black lines) obtained upon
titration of a solution of pa-FPR with a solution of NADP+ (A) and with a solution of ADP
(B). The weighted values of chemical shift perturbations were obtained from
. The red lines in the plot correspond to residues whose
corresponding cross-peaks decrease in intensity and disappeared during the titration. (C)
Residues whose corresponding cross-peaks exhibited gradual chemical shift perturbations
during the titration with NADP+ are highlighted green on the surface of the pa-FPR-NADP
complex, whereas those residues whose cross-peaks decreased in intensity and disappeared
during the titration are highlighted in red. FAD and NADP+ are rendered in yellow and in blue
sticks, respectively. (D) Residues whose cross peaks were affected during the titration of paFPR with ADP have been highlighted as in (C).
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Figure 7.

Stereoviews of (A) possible “electron tunneling path” which starts with the T-stacking of the
nicotinamide ring (cyan) and Phe255 aromatic side chain, continues across the peptide bond
into Ala255 and across its carbonyl oxygen into the isoalloxazine ring of FAD (yellow). (B)
In the context of sequential electron-proton-electron transfer, several structural waters network
the nicotinamide and isoalloxazine reactive sites, suggesting a possible path for proton
translocation. (C) Amino acid sequence alignment of bacterial subclass I FPR enzymes
showing that residues A254, F255 and V256 from the AFVxx motif in the C’-terminal extension
are conserved. The C’-terminal sequence of spinach FNR, highlighting the terminal Tyr of
plastidic FNRs, is shown for comparison.
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Summary of data collection and structure refinementa
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FPR(FAD) - NADP+ complex

Data set

P21212
a=67.14 b=73.49 c=51.54
α=β=γ=90°
2037
[average B-factor = 22.5 Å2]
FAD and NADP+ (101 atoms)
[average FAD B-factor = 19.4 Å2]
[average NADP+ B-factor = 24.4 Å2]
288
[average B-factor = 33.1 Å2]
0.01
1.7
20–1.90 (1.95–1.90)
20561 (2895)
99.7 (99.4)
28.45 (8.44)
3.8 (15.7)
18.1
21.8

Space group
Unit cell dimensions (Å)
Protein atoms
Ligands
Solvent molecules
rmsdb bonds (Å)
rmsdb angles (°)
Resolution range
Unique reflections
Completeness (%)
I/σI
Rmerge (%)
Rcrystc (%)
Rfreed (%)
a

Values in parentheses refer to the highest-resolution shell.
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b

Rootmean-square deviation from ideal values.

c
Rcryst ) 100 * Σ|Fobs - Fmodel|/ΣFobs, where Fobs and Fmodel are observed and calculated structure factor amplitudes, respectively.
d

Rfree is the Rcryst calculated for randomly chosen unique reflections, which were excluded from the refinement (1234 for FPR liganded with FAD).
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